Biotage AB Statistics

Total Valuation

Biotage AB has a market cap or net worth of SEK 12.78 billion. The enterprise value is 12.66 billion.

Market Cap	12.78B
Enterprise Value	12.66B

Important Dates

The next estimated earnings date is Wednesday, February 19, 2025.

Earnings Date	Feb 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Biotage AB has 80.05 million shares outstanding. The number of shares has increased by 13.55% in one year.

Current Share Class	n/a
Shares Outstanding	80.05M
Shares Change (YoY)	+13.55%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	0.57%
Owned by Institutions (%)	61.30%
Float	66.00M

Valuation Ratios

The trailing PE ratio is 49.92 and the forward PE ratio is 38.86. Biotage AB's PEG ratio is 2.23.

PE Ratio	49.92
Forward PE	38.86
PS Ratio	6.04
PB Ratio	3.36
P/TBV Ratio	16.93
P/FCF Ratio	38.98
P/OCF Ratio	n/a
PEG Ratio	2.23

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.21, with an EV/FCF ratio of 38.61.

EV / Earnings	49.28
EV / Sales	5.98
EV / EBITDA	24.21
EV / EBIT	34.32
EV / FCF	38.61

Financial Position

The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.07.

Current Ratio	1.91
Quick Ratio	1.15
Debt / Equity	0.07
Debt / EBITDA	0.48
Debt / FCF	0.76
Interest Coverage	14.76

Financial Efficiency

Return on equity (ROE) is 6.85% and return on invested capital (ROIC) is 5.65%.

Return on Equity (ROE)	6.85%
Return on Assets (ROA)	4.68%
Return on Capital (ROIC)	5.65%
Revenue Per Employee	3.14M
Profits Per Employee	380,741
Employee Count	674
Asset Turnover	0.43
Inventory Turnover	1.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.28% in the last 52 weeks. The beta is 0.85, so Biotage AB's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	+24.28%
50-Day Moving Average	162.09
200-Day Moving Average	174.71
Relative Strength Index (RSI)	49.20
Average Volume (20 Days)	153,080

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotage AB had revenue of SEK 2.12 billion and earned 257.00 million in profits. Earnings per share was 3.20.

Revenue	2.12B
Gross Profit	1.32B
Operating Income	369.00M
Pretax Income	327.00M
Net Income	257.00M
EBITDA	492.00M
EBIT	369.00M
Earnings Per Share (EPS)	3.20

Full Income Statement

Balance Sheet

The company has 370.00 million in cash and 250.00 million in debt, giving a net cash position of 120.00 million or 1.50 per share.

Cash & Cash Equivalents	370.00M
Total Debt	250.00M
Net Cash	120.00M
Net Cash Per Share	1.50
Equity (Book Value)	3.81B
Book Value Per Share	47.60
Working Capital	590.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 406.00 million and capital expenditures -78.00 million, giving a free cash flow of 328.00 million.

Operating Cash Flow	406.00M
Capital Expenditures	-78.00M
Free Cash Flow	328.00M
FCF Per Share	4.10

Full Cash Flow Statement

Margins

Gross margin is 62.49%, with operating and profit margins of 17.43% and 12.14%.

Gross Margin	62.49%
Operating Margin	17.43%
Pretax Margin	15.45%
Profit Margin	12.14%
EBITDA Margin	23.24%
EBIT Margin	17.43%
FCF Margin	15.49%

Dividends & Yields

This stock pays an annual dividend of 1.60, which amounts to a dividend yield of 1.00%.

Dividend Per Share	1.60
Dividend Yield	1.00%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	49.81%
Buyback Yield	-13.55%
Shareholder Yield	-12.55%
Earnings Yield	2.00%
FCF Yield	2.57%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biotage AB has an Altman Z-Score of 8.41.

Altman Z-Score	8.41
Piotroski F-Score	n/a